Last reviewed · How we verify

NCT03961711

Telemedicine in Total Hip Arthroplasty and Total Knee Arthroplasty

Completed NA Last updated 4 August 2020
What this trial tests

NA trial testing Telemedicine in Knee Osteoarthritis in 98 participants. Completed in 22 May 2020.

Timeline
10 May 2019
Primary endpoint
22 May 2020
22 May 2020

Quick facts

Lead sponsorThe Hawkins Foundation
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment98
Start date10 May 2019
Primary completion22 May 2020
Estimated completion22 May 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

The Hawkins Foundation

Who can join

18 and older, any sex, with Knee Osteoarthritis or Hip Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to evaluate patient perspective on telemedicine used in 3 week post operative visits for knee and hip arthroplasty. It is hypothesized that patient satisfaction with telemedicine follow-up is equal to patient satisfaction with in-office followup. Patient satisfaction will be assessed at the 3-week and 9-week post-operative timepoints.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Telemedicine

Trials testing the same drug.

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

Other The Hawkins Foundation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03961711.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing